Valuation AstraZeneca PLC Nasdaq Stockholm

Stocks

Market Closed - Nasdaq Stockholm 17:00:00 09/10/2026 BST			5-day change	1st Jan Change
1,591.50 ^SEK	+1.08%		+1.11%	-6.57%

10-09	Daiichi Sankyo, AstraZeneca's Datroway Gets China's Approval for Second Breast Cancer Indication	MT
10-08	Guardant Gets European Approval for Guardant360 as Companion Diagnostic for AstraZeneca's Etcamah in Breast Cancer	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	246,254	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-14.44%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	266,300	258,629	249,992
Change	-	12.57%	-0.25%	-1.74%	36.64%	-14.42%	-2.88%	-3.34%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	20.6x	17.6x	15.7x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.55x	3.96x	3.41x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.1x	1.3x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	3.9x	3.67x	3.46x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.22x	3.86x	3.51x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.1x	10.6x	9.32x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	12.7x	11.2x	9.82x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	27.8x	20x	17.1x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.6%	5%	5.83%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.34	3.543	3.654
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.1%	2.23%	2.3%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.717	9.008	10.13
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	43.3%	39.3%	36.1%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,172	67,050	71,122
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,079	24,312	26,810
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,037	23,157	25,468
Net income ¹	112	3,288	5,961	7,035	10,225	11,900	13,838	15,531
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,045	12,375	3,738
Reference price ²	117.51	135.16	135.02	131.05	185.60	158.77	158.77	158.77
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	10/02/22	09/02/23	08/02/24	06/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.55x	12.18x	25.21x	0.58%	1,051B
JOHNSON & JOHNSON	29.08x	6.43x	18.37x	2.04%	630B
ABBVIE INC.	35.19x	8.13x	16.76x	2.51%	489B
MERCK & CO., INC.	105.8x	5.93x	25.27x	2.34%	359B
ROCHE HOLDING AG	19.31x	4.72x	11.72x	2.8%	344B
NOVARTIS AG	20.06x	5.27x	12.98x	3.02%	272B
ASTRAZENECA PLC	20.57x	4.22x	12.06x	2.1%	246B
AMGEN INC.	26.34x	6.83x	12.21x	2.43%	224B
GILEAD SCIENCES, INC.	-45.84x	6.75x	26.31x	2.18%	187B
Average	27.12x	6.72x	17.88x	2.22%	422.63B
Weighted average by Cap.	32.41x	7.85x	19.34x	1.9%